Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308142453> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4308142453 endingPage "A715" @default.
- W4308142453 startingPage "A714" @default.
- W4308142453 abstract "Abstract Objectives Estetrol (E4), a native estrogen produced by the fetal human liver, has four hydroxyl-groups, making it structurally distinct from other estrogens. We determined the human metabolic profile of E4, which is recently marketed combined with drospirenone as a novel contraceptive and is currently in development for the relief of menopausal symptoms. Method: We studied the in vitro metabolism of E4 using human hepatocytes, human liver microsomes and recombinant CYP enzymes in reaction phenotyping studies to evaluate the role of human cytochrome P450 enzymes, UDP-glucuronosyltransferases (UGT) and sulfotransferases (SULT). Furthermore, we evaluated the in vivo metabolism of E4 in an open-label, non-randomised phase 1 human absorption, distribution, metabolism, and excretion study, in which six healthy postmenopausal participants received a single oral solution containing 15 mg [14C]-E4. We analysed blood (up to 240h), urine and faecal samples (up to 312h). Metabolite profiling and identification was performed using liquid chromatography with tandem mass spectrometry. Results The in vitro studies showed that E4 undergoes extensive phase 2 metabolism to form glucuronide and sulphate conjugates. UGT2B7 is the key enzyme catalysing the direct glucuronidation of E4 and SULT1E1 is the dominant sulfotransferase for sulphate conjugation in vitro. Unlike for other estrogens, oxidative phase 1 metabolism by P450 enzymes does not play a major role in the metabolism of E4. Following oral administration of E4 to humans, the major metabolites observed in human plasma were E4-16-glucuronide, E4-3-glucuronide and E4-glucuronide-sulfate (respectively 62%, 17% and 9% of radioactivity at the time of maximum plasma concentration [Tmax]). At Tmax, unchanged E4 accounts for only 7.5% of plasma radioactivity. Main metabolites quantified in urine during the first 6 hours after administration were E4-16-glucuronide and E4-3-glucuronide (respectively 77.4% and 16.5% of urine radioactivity). Approximately 69% of the total administered radioactivity was recovered in urine and 22% in faeces. Mass spectrometry showed that E4 was not present in urine but was detected in faeces and that E4 is not converted back into one of the other natural estrogens (estriol, estradiol, estrone). Conclusions Altogether, these data suggest that E4 has a unique metabolic profile. E4 is a terminal end-product of estrogen metabolism, which is not converted back, in vivo, into active metabolites like estriol, estradiol or estrone. Unlike for other estrogens, CYP450 enzymes do not play a major role in the metabolic pathway of E4. Presentation: Monday, June 13, 2022 12:30 p.m. - 2:30 p.m., Monday, June 13, 2022 12:48 p.m. - 12:53 p.m." @default.
- W4308142453 created "2022-11-08" @default.
- W4308142453 creator A5003297593 @default.
- W4308142453 creator A5035393567 @default.
- W4308142453 creator A5053683513 @default.
- W4308142453 creator A5063145552 @default.
- W4308142453 creator A5069935922 @default.
- W4308142453 creator A5079758378 @default.
- W4308142453 creator A5081675587 @default.
- W4308142453 date "2022-11-01" @default.
- W4308142453 modified "2023-10-13" @default.
- W4308142453 title "RF34 | PMON202 The Human Metabolic Profile of Estetrol" @default.
- W4308142453 doi "https://doi.org/10.1210/jendso/bvac150.1472" @default.
- W4308142453 hasPublicationYear "2022" @default.
- W4308142453 type Work @default.
- W4308142453 citedByCount "1" @default.
- W4308142453 countsByYear W43081424532023 @default.
- W4308142453 crossrefType "journal-article" @default.
- W4308142453 hasAuthorship W4308142453A5003297593 @default.
- W4308142453 hasAuthorship W4308142453A5035393567 @default.
- W4308142453 hasAuthorship W4308142453A5053683513 @default.
- W4308142453 hasAuthorship W4308142453A5063145552 @default.
- W4308142453 hasAuthorship W4308142453A5069935922 @default.
- W4308142453 hasAuthorship W4308142453A5079758378 @default.
- W4308142453 hasAuthorship W4308142453A5081675587 @default.
- W4308142453 hasBestOaLocation W43081424531 @default.
- W4308142453 hasConcept C181199279 @default.
- W4308142453 hasConcept C185592680 @default.
- W4308142453 hasConcept C2775904581 @default.
- W4308142453 hasConcept C2777477808 @default.
- W4308142453 hasConcept C2779186261 @default.
- W4308142453 hasConcept C2779907587 @default.
- W4308142453 hasConcept C526171541 @default.
- W4308142453 hasConcept C55493867 @default.
- W4308142453 hasConcept C62231903 @default.
- W4308142453 hasConcept C86803240 @default.
- W4308142453 hasConcept C87644729 @default.
- W4308142453 hasConcept C98274493 @default.
- W4308142453 hasConceptScore W4308142453C181199279 @default.
- W4308142453 hasConceptScore W4308142453C185592680 @default.
- W4308142453 hasConceptScore W4308142453C2775904581 @default.
- W4308142453 hasConceptScore W4308142453C2777477808 @default.
- W4308142453 hasConceptScore W4308142453C2779186261 @default.
- W4308142453 hasConceptScore W4308142453C2779907587 @default.
- W4308142453 hasConceptScore W4308142453C526171541 @default.
- W4308142453 hasConceptScore W4308142453C55493867 @default.
- W4308142453 hasConceptScore W4308142453C62231903 @default.
- W4308142453 hasConceptScore W4308142453C86803240 @default.
- W4308142453 hasConceptScore W4308142453C87644729 @default.
- W4308142453 hasConceptScore W4308142453C98274493 @default.
- W4308142453 hasIssue "Supplement_1" @default.
- W4308142453 hasLocation W43081424531 @default.
- W4308142453 hasLocation W43081424532 @default.
- W4308142453 hasOpenAccess W4308142453 @default.
- W4308142453 hasPrimaryLocation W43081424531 @default.
- W4308142453 hasRelatedWork W2015745909 @default.
- W4308142453 hasRelatedWork W2027761686 @default.
- W4308142453 hasRelatedWork W2040052389 @default.
- W4308142453 hasRelatedWork W2050115426 @default.
- W4308142453 hasRelatedWork W2071534727 @default.
- W4308142453 hasRelatedWork W2098811551 @default.
- W4308142453 hasRelatedWork W2104519644 @default.
- W4308142453 hasRelatedWork W2127130326 @default.
- W4308142453 hasRelatedWork W2133668097 @default.
- W4308142453 hasRelatedWork W2147593455 @default.
- W4308142453 hasVolume "6" @default.
- W4308142453 isParatext "false" @default.
- W4308142453 isRetracted "false" @default.
- W4308142453 workType "article" @default.